| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Rapid Communications |
Translational Research Laboratory (O.G., D.J.M., P.L.M.D., C.E.), Human Cancer Genetics Unit, Program in Population Sciences, Department of Adult Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; Molecular Genetics Laboratory (S.D.A., B.G.R.), Kolling Institute for Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, NSW, Australia; Department of Surgery (A.F.), Eppendorf University of Hamburg, Hamburg, Germany; Departments of Pathology and Paediatrics (L.M.M.) Queens University, Kingston, Ontario, Canada; Department of Medicine (J.D.Z.), The Royal Melbourne Hospital, Parkville, Victoria, Australia Cancer Research Campaign Human Cancer Genetics Research Group (C.E.), University of Cambridge, Cambridge, United Kingdom
Address correspondence and reprint requests to: Charis Eng, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115-6084.
Abstract
The autosomal dominant multiple endocrine neoplasia type 2 syndromes (MEN 2) comprise three clinically distinct entities, MEN 2A, familial medullary thyroid carcinoma and MEN 2B, which share a common clinical feature: medullary thyroid carcinoma (MTC). MEN 2B is considered to have the most aggressive form of MTC. Therefore, early detection of MEN 2B in order to prevent potentially lethal MTC is important. More than 95% of all MEN 2B cases are caused by germline mutation at codon 918 (M918T) in exon 16 of the RET proto-oncogene. In this study, we demonstrate the presence of germline codon 883 mutation (A883F) in 2 of 3 unrelated MEN 2B cases without codon 918 mutation. Our data demonstrate a novel etiologic event which may have roles in predisposition to MEN 2B when present in the germline and in the pathogenesis of sporadic MTC when somatic.
Received September 15, 1997.
Revised October 1, 1997.
Accepted October 1, 1997.
This article has been cited by other articles:
![]() |
R. L. Margraf, R. Mao, and C. T. Wittwer Rapid Diagnosis of MEN2B Using Unlabeled Probe Melting Analysis and the LightCycler 480 Instrument J. Mol. Diagn., March 1, 2008; 10(2): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Cranston, C. Carniti, K. Oakhill, E. Radzio-Andzelm, E. A. Stone, A. S. McCallion, S. Hodgson, S. Clarke, P. Mondellini, J. Leyland, et al. RET Is Constitutively Activated by Novel Tandem Mutations that Alter the Active Site Resulting in Multiple Endocrine Neoplasia Type 2B. Cancer Res., October 15, 2006; 66(20): 10179 - 10187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors Endocr. Rev., August 1, 2006; 27(5): 535 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cranston, C. Carniti, S. Martin, P. Mondellini, Y. Hooks, J. Leyland, S. Hodgson, S. Clarke, M. Pierotti, B. A. J. Ponder, et al. A Novel Activating Mutation in the RET Tyrosine Kinase Domain Mediates Neoplastic Transformation Mol. Endocrinol., July 1, 2006; 20(7): 1633 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Elisei, B. Cosci, C. Romei, L. Agate, P. Piampiani, P. Miccoli, P. Berti, F. Basolo, C. Ugolini, R. Ciampi, et al. Identification of a Novel Point Mutation in the RET Gene (Ala883Thr), Which Is Associated with Medullary Thyroid Carcinoma Phenotype Only in Homozygous Condition J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5823 - 5827. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jimenez, M. A. Habra, S.-C. E. Huang, A. El-Naggar, S. E. Shapiro, D. B. Evans, G. Cote, and R. F. Gagel Pheochromocytoma and Medullary Thyroid Carcinoma: A New Genotype-Phenotype Correlation of the RET Protooncogene 891 Germline Mutation J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4142 - 4145. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jimenez, G. T. Dang, P. N. Schultz, A. El-Naggar, S. Shapiro, E. A. Barnes, D. B. Evans, R. Vassilopoulou-Sellin, R. F. Gagel, G. J. Cote, et al. A Novel Point Mutation of the RET Protooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3521 - 3526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Kruckeberg and S. N. Thibodeau Pyrosequencing Technology as a Method for the Diagnosis of Multiple Endocrine Neoplasia Type 2 Clin. Chem., March 1, 2004; 50(3): 522 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Marsh, G. Theodosopoulos, K. Martin-Schulte, A.-L. Richardson, J. Philips, H.-D. Roher, L. Delbridge, and B. G. Robinson Genome-Wide Copy Number Imbalances Identified in Familial and Sporadic Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1866 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Maher and C. Eng The pressure rises: update on the genetics of phaeochromocytoma Hum. Mol. Genet., October 1, 2002; 11(20): 2347 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Lesueur, M Corbex, J D McKay, J Lima, P Soares, P Griseri, J Burgess, I Ceccherini, S Landolfi, M Papotti, et al. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma J. Med. Genet., April 1, 2002; 39(4): 260 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Niccoli-Sire, A. Murat, V. Rohmer, S. Franc, G. Chabrier, L. Baldet, B. Maes, F. Savagner, S. Giraud, S. Bezieau, et al. Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3746 - 3753. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Lee, H.-C. Liu, H.-C. Lee, C.-Y. Tzen, C.-Y. Huang, and T.-L. Yang Picture of the Month Arch Pediatr Adolesc Med, July 1, 2001; 155(7): 845 - 846. [Full Text] [PDF] |
||||
![]() |
O. Gimm, H. Chi, P. L. M. Dahia, A. Perren, R. Hinze, P. Komminoth, H. Dralle, P. R. Reynolds, and C. Eng Somatic Mutation and Germline Variants of MINPP1, a Phosphatase Gene Located in Proximity to PTEN on 10q23.3, in Follicular Thyroid Carcinomas J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1801 - 1805. [Abstract] [Full Text] |
||||
![]() |
M. Wiench, Z. Wygoda, E. Gubala, J. Wloch, K. Lisowska, J. Krassowski, D. Scieglinska, A. Fiszer-Kierzkowska, D. Lange, D. Kula, et al. Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic Patients J. Clin. Oncol., March 1, 2001; 19(5): 1374 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Hansford and L. M Mulligan Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis J. Med. Genet., November 1, 2000; 37(11): 817 - 827. [Abstract] [Full Text] |
||||
![]() |
K. Kawai, T. Iwashita, H. Murakami, N. Hiraiwa, A. Yoshiki, M. Kusakabe, K. Ono, K.-i. Iida, A. Nakayama, and M. Takahashi Tissue-specific Carcinogenesis in Transgenic Mice Expressing the RET Proto-Oncogene with a Multiple Endocrine Neoplasia Type 2A Mutation Cancer Res., September 1, 2000; 60(18): 5254 - 5260. [Abstract] [Full Text] |
||||
![]() |
O. Gimm, A. Greco, C. Hoang-Vu, H. Dralle, M. A. Pierotti, and C. Eng Mutation Analysis Reveals Novel Sequence Variants in NTRK1 in Sporadic Human Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2784 - 2787. [Abstract] [Full Text] |
||||
![]() |
V V Smith, C Eng, and P J Milla Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment Gut, July 1, 1999; 45(1): 143 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pigny, C. Bauters, J.-L. Wemeau, M. Lecomte Houcke, M. Crepin, P. Caron, S. Giraud, A. Calender, M.-P. Buisine, J.-P. Kerckaert, et al. A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1700 - 1704. [Abstract] [Full Text] |
||||
![]() |
T. Takano, A. Miyauchi, F. Matsuzuka, G. Liu, T. Higashiyama, T. Yokozawa, K. Kuma, and N. Amino Preoperative Diagnosis of Medullary Thyroid Carcinoma by RT-PCR Using RNA Extracted from Leftover Cells within a Needle Used for Fine Needle Aspiration Biopsy J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 951 - 955. [Abstract] [Full Text] |
||||
![]() |
C. Eng RET Proto-Oncogene in the Development of Human Cancer J. Clin. Oncol., January 1, 1999; 17(1): 380 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Eng, D. J. Marsh, B. G. Robinson, C. W. Chow, M. A. Patton, M. C. Southey, D. J. Venter, B. A. J. Ponder, P. J. Milla, and V. V. Smith Germline RET Codon 918 Mutation in Apparently Isolated Intestinal Ganglioneuromatosis J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4191 - 4194. [Full Text] |
||||
![]() |
C. Eng, G. A. Thomas, D. S. Neuberg, L. M. Mulligan, C. S. Healey, C. Houghton, A. Frilling, F. Raue, E. D. Williams, and B. A. J. Ponder Mutation of the RET Proto-Oncogene Is Correlated with RET Immunostaining in Subpopulations of Cells in Sporadic Medullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4310 - 4313. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |